Haas Jason
Syros Pharmaceuticals, Inc. · Chief Financial Officer
Haas Jason is listed in public filings as officer: Chief Financial Officer. This Haas Jason insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Syros Pharmaceuticals, Inc. (SYRS), and Ligand Pharmaceuticals Incorporated (LGND). Investors use Haas Jason's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $693k2.9k shares | Grant / ExerciseJun 5, 2026 | $696.3K2.9k shares | $237.00 | $235.89 |